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Abstract
Background: The lysis-lysogeny decision in the temperate coliphage l is influenced by a number of phage
proteins (CII and CIII) as well as host factors, viz. Escherichia coli HflB, HflKC and HflD. Prominent among these are
the transcription factor CII and HflB, an ATP-dependent protease that degrades CII. Stabilization of CII promotes
lysogeny, while its destabilization induces the lytic mode of development. All other factors that influence the lytic/
lysogenic decision are known to act by their effects on the stability of CII. Deletion of hflKC has no effect on the
stability of CII. However, when l infects ΔhflKC cells, turbid plaques are produced, indicating stabilization of CII
under these conditions.
Results: We find that CII is stabilized in ΔhflKC cells even without infection by l, if CIII is present. Nevertheless, we
also obtained turbid plaques when a ΔhflKC host was infected by a cIII-defective phage (lcIII67). This observation
raises a fundamental question: does lysogeny necessarily correlate with the stabilization of CII? Our experiments
indicate that CII is indeed stabilized under these conditions, implying that stabilization of CII is possible in ΔhflKC
cells even in the absence of CIII, leading to lysogeny.
Conclusion: We propose that a yet unidentified CII-stabilizing factor in l may influence the lysis-lysogeny decision
in ΔhflKC cells.
Background
After it infects host E. coli cells, bacteriophage l follows
either of two fates, lytic or lysogenic. How the virus
decides which pathway to follow after infection depends
upon a complex genetic circuit. An increase in the num-
ber of infecting phages converts the decision making
process from a deterministic to a stochastic one, with
the cell fate depending on the number of phages decid-
ing in favour of lysogeny [1,2]. There are phage coded
proteins and transcription factors [3-5] dedicated for
this decision making process, but host factors are also
involved [6-9]. Mutations in the cI, cII and cIII genes of
l [10] enhances the lytic frequency (leading to clear pla-
que formation, hence the names) and therefore the pro-
ducts of these genes were thought to be responsible for
the establishment of lysogeny. CII, the key tetrameric
transcription factor for lysogenic establishment, is a very
unstable protein [7,11,12] and its presence in sufficient
amounts is crucial for the lysogenic choice [13-15].
Other factors such as lCIII and the host hfl proteins
that influence the lysis-lysogeny switching affect the sta-
bility of CII in one way or the other. lCIII promotes
lysogeny by acting as a general inhibitor of E. coli HflB
that degrades CII [16].
Mutations in the host hfl loci cause an infecting l
particle to follow the lysogenic mode. These genes
therefore encode factors that somehow destabilize CII.
Primarily from mutational studies, two such loci, hflA
and hflB, were initially identified. The product of the
latter gene, HflB, is an ATP-dependent metalloprotease
known as a ‘quality control’ protease that removes mis-
folded proteins produced due to rapid translation dur-
ing good nutrient conditions [17,18]. CII is also a
substrate of HflB [7] and thus acts as a sensor for cel-
lular nutrient conditions of the host. Rapid degradation
of CII in cells growing in rich media thus favors the
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lytic development [13,14]. The hflA locus consists of
the genes hflX, hflK and hflC that are under the con-
trol of the same promoter [19-22]. Of these, hflX has
been demonstrated to have no role in lambda lysogeny
[23]. The products of the other two, HflK and HflC,
are tightly associated with each other and copurify as
the ‘HflKC’ complex, which was earlier thought to be a
protease [24]. Subsequently, HflKC was found only to
act as a ‘modulator’ of HflB by forming a complex
with the latter [25-27]. The only other known E. coli
factor in this process, HflD [9], has been shown to
inhibit CII-mediated activation of transcription by
impairing the DNA-binding ability of CII [28].
HflKC antagonizes the action of HflB towards the
membrane associated substrates of the latter [18,25].
The behavior of HflKC with respect to the cytosolic
substrates of HflB (such as lCII), however, remains
unclear. Likewise, the role of HflKC in the lysis-lysogeny
decision of l is not well understood. Though an ‘hfl’
protein, mutations in whose gene(s) causes an increase
in the lysogenic frequency of l [6], the deletion of these
genes has little effect on the in vivo stability of exogen-
ous CII [26]. CII expressed from a plasmid is found to
be stabilized in an hflKC-deleted cell, only if the host is
simultaneously infected with a lambda phage [26]. On
the other hand, E. coli cells overexpressing HflKC exhi-
bit an enhanced frequency of lysogenization [26]. These
results lead to a paradox: lysogeny increases both upon
deletion or overexpression of HflKC. Therefore, the role
of HflKC in the l lysis-lysogeny switch merits further
investigations.
Methods
Plasmids, bacterial strains and phages
Plasmid pQKC was constructed by PCR cloning of the
hflK and hflC ORFs (not fused, because the genomic
region between these two contains the stop codon for
hflK and the RBS for hflC) between the BamHI and SalI
sites of pQE30 (purchased from Qiagen, contains the
phage T5 promoter under the control of a Lac operator).
Construction of pKP219 (which contains the cII gene
under the lac promoter LacP and a P15A replication
origin) has been described earlier [28]. Plasmid pC2C3
(containing the cII and cIII genes) was constructed in
three steps. First, the NdeI-BamHI fragment of pAB905
containing the cIII gene [29] was cloned into pKP07
[28] and was named pLaCIII (containing the cIII gene
under LacP). Then the BglII-XhoI fragment of pLaCIII
(i.e. the cIII gene along with the LacP) was cloned into
the compatible BamHI-XhoI sites of pKP106 (which
already contained the cII gene under LacP) [28]. The
resulting plasmid was named pLaC2C3. In the final step
the BamHI-BglII fragment of pLaC2C3 (containing both
cII and cIII under individual LacP promoters) was
cloned into the linearized arm of pK109 (having a P15A
origin of replication) [30] at the BglII site.
For wild type E. coli, the strain MG1655 (F- l- ilvG
rfb-50 rph-1) was used. The strain AK990 [26] (ΔhflKC::
Kan) served as cells with mutant hflKC.
The phage strain lcIII67 was used as the CIII-defective
phage. In this strain, a G to T mutation in the 23rd
nucleotide of the cIII ORF leads to an alternative struc-
ture of the cIII mRNA that is incapable of translation
[31]. This is one of the most effective cIII mutants [32]
and has been used as cIII- by many workers.
Purification of proteins
For the purification of the HflKC complex, XL1Blue
cells carrying pQKC was used and 100 μg/ml of ampicil-
lin was used for selection. 7.5 ml of the overnight satu-
rated culture was inoculated into 750 ml of fresh M9
medium with the appropriate antibiotic and allowed to
grow on a 37°C shaker incubator till the culture O.D.
(at 600 nm) was 0.4-0.5. The culture was then cooled to
18°C and induced by 500 μM IPTG, followed by further
growth at 18°C with constant shaking (at 100 rpm) for
20 hours. After induction, bacterial cells were recovered
by centrifugation at 3000 g for 10 minutes in Sorvall
RC5C, using an SA600 rotor, at 4°C. The medium was
decanted out and the pellet was washed with 0.9% NaCl
and dissolved in 20 ml of lysis buffer (20 mM TRIS-
HCl, pH 8.0, 100 mM KCl, 10% glycerol, 5 mM imida-
zole, 0.5% NP40, bacterial protease inhibitor cocktail
(MBI Fermentas) and 200 μg/ml lysozyme). Cells were
then lysed by sonication with 5 pulses (at a pulse rate of
10 mV/30 seconds), followed by centrifugation at 26000
g for 30 minutes at 4°C. The supernatant was collected
into a fresh tube and loaded on to a Ni+2-NTA column,
pre-equilibrated with the lysis buffer. After loading, the
column was washed with wash buffer (20 mM TRIS-
HCl, pH 8.0, 600 mM KCl, 10% glycerol, 15 mM imida-
zole). Proteins were eluted from the column using the
elution buffer (20 mM TRIS-HCl, pH 8.0, 100 mM KCl,
10% glycerol, 0.1% NP40, 300 mM imidazole). Imidazole
was removed by dialysis in 20 mM TRIS-HCl, pH 8.0,
100 mM KCl, 10% glycerol, 0.1% NP40).
Native CII [33] and GST-HflB [29] were purified as
described earlier.
In vitro proteolysis of CII
HflB mediated proteolysis of CII was carried out in buf-
fer P (50 mM Tris-acetate, 100 mM NaCl, 5 mM
MgCl2, 25 μM Zn-acetate, 1.4 mM b-ME; pH 7.2). ATP
was added to a concentration of 5 mM in all the reac-
tion mixtures. 8 μM of CII was taken with 1 μM of pur-
ified GST-HflB in a 30 μl reaction mix. The reactions
were incubated at 37°C for the specified time intervals
followed by the addition of SDS-PAGE loading buffer
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and heating in a boiling water bath for 5 minutes. The
samples were analyzed on a 15% SDS-PAGE. The effect
of HflKC on the proteolysis of CII was observed by the
addition of His-HflKC (up to 2 μM) to GST-HflB prior
to the addition of CII. The band corresponding to CII
was quantitated by volume analysis (software used: Ver-
sadoc (Bio rad) Quantity-1) and used as the amount of
CII remaining (expressed as the percentage of the
amount of CII at zero time) after the specified time.
In vivo proteolysis of CII
In vivo proteolysis of CII was carried out in E. coli
MG1655 cells (having wild type HflB) transformed with
pKP219 or pC2C3, both of which contained cII under
Lac promoter. In addition, pC2C3 contained cIII under
a second Lac promoter. Cells carrying pKP219 or
pC2C3 were inoculated in 10 ml of LB medium supple-
mented with 50 μg/ml kanamycin. Expression of CII
was induced by 1 mM IPTG after the O.D. of the cul-
ture (at 600 nm) had reached 0.6. The culture was
further grown at 37°C for another 30 minutes, followed
by the addition of 10 μg/ml spectinomycin to arrest
further protein synthesis. Samples were taken out at reg-
ular intervals after spectinomycin addition, and immedi-
ately centrifuged to pellet the cells. 30 μl of sterile water
and 8 μl of SDS gel loading dye were added to each
sample, followed by immediate boiling and loading onto
a 15% SDS-PAGE. The gel was transferred to a PVDF
membrane (Pierce Biotech) and was blotted with anti-
CII antibody. Each CII band was quantitated by volu-
metric analysis as described above.
The effect of overexpression of hflKC was observed by
transformation of MG1655 cells by plasmid pQKC (plus
pKP219 or pC2C3). The transformed cells were grown
in the presence of both kanamycin and ampicillin. Pro-
moters in both the plasmids are inducible with IPTG.
The effect of deletion of hflKC was observed by trans-
formation of AK9990 cells by pKP219 or pC2C3.
For measurement of the stability of CII under condi-
tions of infection by lcIII67, MG1655 or AK990 cells
carrying pKP219 were grown in Luria broth supplemen-
ted with 0.4% maltose and were infected with the phage
(at an MOI of 10 to ensure that all the cells were
infected), 20 minutes after the addition of IPTG. Specti-
nomycin was added after another 25 minutes to ensure
the entry of phage DNA and the expression of phage
factors. Samples were then taken out at regular intervals
and analyzed as described above.
Assay of plaque morphology
The plaque morphology of lcIII67 was assayed in
E. coli MG1655 (wild type), in MG1655 cells carrying
pQKC, and in strain AK990 (ΔhflKC::Kan). Cells were
grown up to an O.D. (at 600 nm) of 0.6 in Luria broth
supplemented with 0.4% maltose, and were induced
with 500 μM IPTG. A bacterial lawn was made by
pouring 5 ml of soft top agar (0.5% Luria agar supple-
mented with 0.4% maltose) mixed with 300 μl of these
cells onto a 2% Luria agar plate. Another 100 μl of the
above liquid culture was infected with lcIII67 at an
M.O.I. of 0.1. It was further incubated at 32°C for
10 minutes to allow adsorption of the phage. Appro-
priate dilutions were then plated onto the prepared
bacterial lawn and the plates were incubated overnight
at 32°C. The turbidity of plaques formed in AK990
cells or in cells overexpressing HflKC were compared
with the clear plaques formed in wild type cells upon
infection by lcIII67.
Results and Discussion
Role of HflKC on the proteolysis of CII in vivo
E. coli HflKC inhibits the proteolysis of all the membra-
nous substrates of HflB (e.g., SecY, YccA) [18]. How-
ever, the behaviour of HflKC toward lCII, a cytosolic
substrate, is perplexing. The deletion of hflKC as well as
its overexpression causes an increase in the lysogenic
frequency of l [26]. The hflKC genes were first identi-
fied as mutants that caused turbid plaques of l on a
bacterial lawn [6]. It is therefore expected that CII
would be stabilized in an hflKC-deleted host cell. Kihara
et al. [26], however, showed that the deletion of hflKC
has little effect on the stability of CII cloned under an
AraBAD promoter. We obtained similar results when
the effect of hflKC deletion (strain AK990) on the stabi-
lity of CII (cloned under lac promoter) was tested
(Figure 1). Here we measured the stability of CII
expressed from the plasmid pKP219 in wild type and in
AK990 (ΔhflKC) cells. In both cases, CII was unstable.
We also tested the effect of overexpression of HflKC
from a second plasmid (pQKC), and found that in
this case, CII expressed from pKP219 was stabilized
(Figure 1). This data is consistent with in vitro results
that showed that purified HflKC [26,34] inhibits the
proteolysis of CII. The inhibitory activity is an intrinsic
property of HflK and HflC, since HflK or HflC can indi-
vidually inhibit the proteolysis of CII [34].
These results pose an intriguing question. Why does
the deletion of an inhibitor of CII proteolysis promote
lysogeny? One can think of the following possibilities:
(i) A proper assembly of HflB that is necessary for its
activity against cytosolic substrates, may require HflKC;
or (ii) In the absence of HflKC, HflB is guided towards
its membrane-associated substrates [26], indirectly stabi-
lizing the cytosolic substrate CII. However, from in vivo
proteolysis experiments we found that in AK990 cells
(ΔhflKC), exogenous CII was not stabilized (Figure 1),
confirming that HflB was active against CII even in the
absence of hflKC. This result rules out both the
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possibilities mentioned above. It may be noted that simi-
lar results were also obtained by Kihara et al [26].
Therefore, an increase in lambda lysogeny upon overex-
pression of host HflKC [26] is not at all surprising, since
HflKC inhibits the proteolysis of CII.
Effect of increasing concentrations of HflKC on the
proteolysis of CII in vitro
The paradoxical effect of an increase in the lysogenic
frequency of l upon deletion as well as overexpression
of hflKC has been reported [26]. A possible reason
behind this paradox could be that a critical molar ratio
between HflB and HflKC, believed to be 1:1 in wild type
cells [35], is necessary for a proper proteolysis of CII by
HflB. Both the increase or decrease of HflKC would off-
set this critical ratio and could lead to a stabilization of
CII, promoting lysogeny. To examine this possibility, we
carried out the proteolysis of CII by HflB in vitro, in the
presence of three different concentrations of HflKC
(Figure 2). In the first case, when HflKC was absent
(mimicking the deletion of HflKC), CII (8 μM) was
rapidly cleaved by HflB. The rate of proteolysis was
much slower when HflKC was added in a molar ratio of
HflKC:HflB = 1:1. The proteolysis was inhibited further
when HflKC was added in excess (HflKC:HflB = 2:1). If
the above hypothesis was true, proteolysis of CII should
have been maximum at a molar ratio of 1:1. Therefore
we conclude that HflKC acts as a simple inhibitor of CII
proteolysis and the stabilization of CII in the absence of
HflKC may involve other factors.
Role of HflKC on in vivo proteolysis of CII: the effect of CIII
Deletion of hflKC genes lead to an increase in the lyso-
genic frequency of l. Nevertheless, the stability of
cloned CII remained unaffected in ΔhflKC cells. An
interesting phenomenon, however, was observed in
Figure 1 Role of HflKC on in vivo proteolysis of CII. Left panel shows the proteolytic pattern of exogenous CII (expressed from pKP219) in
wild type cells (open circles), AK990 (ΔhflKC, squares) or wild type cells carrying plasmid pQKC (triangles). In each case, the expression of CII was
induced with IPTG and translation was stopped 30 minutes later with spectinomycin. Relative amount of CII was measured after regular intervals
(0, 5, 10, 15, 20 minutes) by western blotting followed by quantification using densitometric analysis. Corresponding western blots showing the
stability of CII in different host strains are shown in the right panel.
Figure 2 Effect of varying concentrations of HflKC on in vitro
proteolysis of CII. CII (8 μM) was treated with GST-HflB (1 μM), in
the presence of His-HflKC in various concentrations: 0 (open circles),
1 μM (squares) and 2 μM (triangles). Samples were taken out at
various time points, run on a 15% SDS-PAGE, and the CII bands
were quantitated by densitometry.
Bandyopadhyay et al. BMC Microbiology 2011, 11:34
http://www.biomedcentral.com/1471-2180/11/34
Page 4 of 8
ΔhflKC cells that were infected by l. CII expressed from
a plasmid was stabilized in these cells [26]. Thus it
appears that some additional factors, supplied by the
infecting phage, caused a stabilization of CII in the
absence of HflKC. The only known phage factor that
favors lysogeny by inhibiting the proteolysis of CII by
HflB, is CIII [29,36]. We therefore tested the possible
involvement of CIII as the l factor responsible for the
above result, viz. stabilization of CII in l-infected
ΔhflKC cells.
We sought to supply lCIII instead of the whole phage
in an hflKC-deleted host and investigate its effect on the
proteolysis of cloned CII. For this purpose, we cloned
cIII in tandem behind cII in the same plasmid and
inserted it in a host with deleted (AK990) or overex-
pressed hflKC. CII was indeed stabilized in these cells,
even without simultaneous infection by l (Figure 3).
Therefore it appears that infection by l stabilized CII in
ΔhflKC cells because it supplied CIII.
CIII is a general inhibitor of CII proteolysis [29,36,37].
It is therefore expected that between a wild type strain
alone and one that carries CIII, CII would exhibit a
greater stability in the latter. A comparison of figures 1
and 3 (open circles) shows that this is indeed the case.
Nonetheless, a greater stability of CII in ΔhflKC cells
compared to wild type (both carrying the CIII-expres-
sing plasmid) is surprising, since the absence of hflKC
does not affect the stability of CII. CIII is itself a
substrate of HflB [38]. If HflKC facilitated the proteoly-
sis of CIII, the above effect could be explained by the
preferential stabilization of CIII in ΔhflKC cells. How-
ever, there was no difference in the in vitro proteolysis
of CIII by HflB in the presence or absence of purified
HflKC (data not shown). Therefore the role of CIII in
this paradoxical effect is indirect.
Are there additional l factors that influence the lysis-
lysogeny decision?
If CIII was the only factor responsible for the stabiliza-
tion of CII in ΔhflKC cells, infection with a cIII-defective
phage would produce clear plaques in a ΔhflKC host.
We tested this possibility by infecting both AK990
(ΔhflKC) cells and hflKC-overexpressing cells with
lambda cIII67 [31,39]. Interestingly, turbid plaques were
obtained in each case, unlike the clear plaques produced
in wild type E. coli (Table 1). This result is really sur-
prising as cIII - phage always produces clear plaques.
Since CIII and HflKC both inhibit the proteolysis of CII,
Figure 3 Role of HflKC on in vivo proteolysis of CII in the
presence of CIII. Proteolytic pattern of exogenous CII (expressed
from pC2C3) in wild type cells (open circles), AK990 (ΔhflKC, squares)
or wild type cells carrying plasmid pQKC (triangles). Experimental
conditions were similar to those used in Figure 1.
Table 1 Plaque morphology upon infection with lcIII67
Genotype of host E. coli cell Plaque morphology
Wild Type Clear
Wild Type + pQKC Turbid
AK990 (ΔhflKC::Kan) Turbid
Figure 4 Effect of infection by cIII-mutant lambda on in vivo
proteolysis of CII. The proteolysis of CII was visualized in wild type
(open circles) or AK990 (diamonds) cells infected with lcIII67. The
expression of CII was induced with IPTG, and the cells were infected
with the phage after 20 minutes. Protein synthesis was stopped
25 minutes later with spectinomycin. The relative amount of CII was
measured at regular intervals by western blotting followed by
quantification using densitometric analysis.
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it is also surprising that the absence of both leads to
increased lysogeny.
Is it then possible that enhancement of lysogeny can
occur through a different mechanism that does not
involve the stabilization of CII? Increase in lambda
lysogeny is invariably linked to the stability of CII in
all published reports to date. Can the two phenomena
be delinked in some special case such as a ΔhflKC
host? We tested this possibility by measuring the stabi-
lity of cloned CII in wild type and ΔhflKC cells, both
infected with lcIII67. A greater stabilization of CII
occurred in ΔhflKC cells (Figure 4). Therefore, an
increase in the lysogenic frequency indeed requires the
stabilization of CII.
This enhanced stabilization of CII is observed only
under conditions of phage infection, even when CIII is
nonfunctional. Therefore in addition to CIII, there
could be another as yet unidentified factor in l
that increases the stability of CII and hence, promotes
lysogeny (see Figure 5A). The presence of such a CII-
stabilizing factor (CSF) can only be demonstrated in
HflKC-deleted cells. Therefore, the activities of CSF
and HflKC must have some connections (Figure 5B).
Likewise, CIII and HflKC are likely to be connected as
Figure 5 The effect of deletion or overexpression of hflKC on l lysogeny and on the stability of CII: A summary of results and
possible mechanisms. (A) A summary of results published previously as well as reported in this study is shown schematically. Some
unanswered questions that remain are highlighted in the boxes. (B) Mechanisms for the stability of CII and the lysogenic outcome under various
conditions are shown. HflB acts upon CII to digest CII, as indicated by the arrow. This digestion is inhibited by HflKC, by CIII or by the postulated
CII-stabilizing factor CSF. The levels of inhibition are denoted by the lengths of the blunt lines. Possible crosstalk between HflKC and CIII or CSF
are indicated by curved arrows. Dashed arrows denote lack of crosstalk. HflKC, CIII or CSF inhibits the digestion of CII. In wild type E. coli cells,
this inhibition is unable to sufficiently stabilize CII, leading to normal plaques (left panel). When HflKC is overexpressed, CII is stabilized better by
the action of HflKC, and turbid plaques are produced (middle panel), while in Δ hflKC cells, CIII and/or CSF act better to stabilize CII, giving rise
to turbid plaques (right panel).
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well. The different outcomes for deletion or overex-
pression of hflKC on lysogeny as well as on the stabi-
lity of CII under various conditions are summarized in
Figure 5A.
The unknown factor CSF could have been a non-pro-
tein factor (i.e, DNA) and lambda DNA would have
been a good candidate for the same, since CII may be
stabilized by binding to its cognate promoter. However,
in our in vivo experiments, the plasmid pKP219 (used
for the expression of exogenous CII) contained the pro-
moter sequence PE, ruling out such a possibility.
Stabilization of CII in cells overexpressing hflKC is not
surprising since HflKC is an inhibitor of CII-proteolysis.
It is worthwhile to note that the effect of HflKC deletion
is epistatic over the effect of cIII deletion, since even the
absence of CIII cannot produce clear plaques in a
ΔhflKC host. It is possible that CIII (and the hypothe-
sized CIII-like factor CSF) works better in the absence
of HflKC (Figure 5B). Therefore CII is better stabilized
under these conditions and produces turbid plaques in
ΔhflKC cells. cI, cII and cIII were first described as
phage mutations which led to clear plaques in a wild
type host. On the other hand, l gives very turbid pla-
ques in a ΔhflKC host. Our study thereby raises the pos-
sibility of finding novel phage mutations that would give
clear plaques in an hflKC-deleted host.
Conclusions
1. E. coli HflKC inhibits the proteolysis of lCII by HflB
and hence the overexpression of the former results in
an increase in the lysogenic frequency.
2. In the absence of HflKC, lCII is stabilized upon
infection by cIII-defective l, suggesting the presence of
a yet unidentified phage factor CSF (CII-stabilizing
factor).
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